FDA grants Priority Review to Roche's inavolisib for
Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options1,2Additional...
Source: globenewswire.com
📰 Roche Group News
Page 2 - Roche Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roche Group. Real-time updates on events, politics, business and more.
BioNTech SE: BioNTech and CEPI Expand Partnership to Strengthen Africa's mRNA Vaccine Ecosystem
BioNTech and CEPI aim to enhance local R&D, clinical and commercial-scale manufacturing capacities to develop potential mRNA vaccines in Africa, for AfricaCEPI to fund up to $145 million to support BioNTech
Source: finanznachrichten.de
BioNTech and CEPI Expand Partnership to Strengthen Africa's mRNA Vaccine Ecosystem
BioNTech and CEPI aim to enhance local R&D, clinical and commercial-scale manufacturing capacities to develop potential mRNA vaccines in Africa, for AfricaCEPI to fund up to $145 million to support...
Source: marketscreener.com
Hitachi, Ltd.: Roche and Hitachi High-Tech extend their long-standing partnership
TOKYO, May 28, 2024 - (JCN Newswire) - Hitachi High-Tech Corporation announced that Roche and Hitachi High-Tech have extended their partnership, committing to at least 10 years of additional collaboration.
Source: finanznachrichten.de
Changes to the Roche Enlarged Corporate Executive Committee
Basel, 27 May 2024 - Roche announced today that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head...
Source: marketscreener.com
F. Hoffmann-La Roche Ltd: Changes to the Roche Enlarged Corporate Executive Committee
Basel, 27 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that James Sabry (1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry
Source: finanznachrichten.de
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
/PRNewswire/ -- Roche announced today that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional...
Source: prnewswire.com
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing - Roche Holding (OTC:RHHBY)
Renewed partnership combines best in class engineering capabilities with cutting edge science to accelerate the availability of new solutions for customers and patients worldwideUpcoming launches of the new cobas®
Source: benzinga.com
Confidential Information Provided to Genentech Leaked in Third-Party Lash Group Data Breach | Console and Associates, P.C.
On May 20, 2024, Lash Group filed a notice of data breach with the multiple state attorney general offices disclosing a data breach affecting information provided to the Lash Group by...
Fort Mill South Carolina United States South San Francisco Flash Group Amerisourcebergen Corporation
Source: jdsupra.com
Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk
Approximately one in five people worldwide have elevated Lp levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics...
Source: marketscreener.com